NovAliX Turns to High-Resolution Cryo-Transmission Electron Microscopy for Pre-Clinical Drug Discovery Research
Thermo Fisher Scientific’s Cryo-TEM provides critical information for small molecule and biologic drug discovery
NovAliX signs insourcing agreement with UCB Biopharma
UCB Biopharma, a Belgian biopharmaceutical company, is the latest addition to NovAliX’s growing client portfolio, which already includes five of the top 50 global pharma companies
5th NovAliX Conference: Biophysics in Drug Discovery 2018
For its fifth edition, the NovAliX Conference “Biophysics in Drug Discovery” will be held for the first time in the US and will take place at the Hilton Back Bay in Boston, MA. 13-15 June, 2018
NovAliX is a Contract Research Organization with chemistry and biophysical techniques. The integrated drug discovery solutions serve pharmaceutical, biotechnology companies and research institutions. Our commitment and reliability are much appreciated by a worldwide client base.